DK0828721T3 - 2-Aminobenzoxazinoner til behandling af virale infektioner - Google Patents

2-Aminobenzoxazinoner til behandling af virale infektioner

Info

Publication number
DK0828721T3
DK0828721T3 DK96914762T DK96914762T DK0828721T3 DK 0828721 T3 DK0828721 T3 DK 0828721T3 DK 96914762 T DK96914762 T DK 96914762T DK 96914762 T DK96914762 T DK 96914762T DK 0828721 T3 DK0828721 T3 DK 0828721T3
Authority
DK
Denmark
Prior art keywords
treatment
viral infections
aminobenzoxazinones
compounds
pharmaceutically
Prior art date
Application number
DK96914762T
Other languages
English (en)
Inventor
Daniel L Flynn
Clara I Villamil
Roger A Nosal
Norman Abood
Daniel P Becker
Brian M Bax
Hui Li
Lori A Schretzman
Michael J Bennett
John L Bedell
Kenneth Williams
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Priority claimed from US09/502,038 external-priority patent/US6380189B1/en
Application granted granted Critical
Publication of DK0828721T3 publication Critical patent/DK0828721T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK96914762T 1995-05-24 1996-05-23 2-Aminobenzoxazinoner til behandling af virale infektioner DK0828721T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/448,795 US5985872A (en) 1995-05-24 1995-05-24 2-amino-benzoxazinones for the treatment of viral infections
PCT/US1996/007526 WO1996037485A1 (en) 1995-05-24 1996-05-23 2-amino-benzoxazinones for the treatment of viral infections
US95262498A 1998-05-15 1998-05-15
US09/502,038 US6380189B1 (en) 1995-05-24 2000-02-11 2-amino benzoxazinones for the treatment of viral infections
US10/035,433 US6683077B2 (en) 1995-05-24 2002-01-04 2-Amino-benzoxazinones for the treatment of viral infections

Publications (1)

Publication Number Publication Date
DK0828721T3 true DK0828721T3 (da) 2002-03-04

Family

ID=37772666

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96914762T DK0828721T3 (da) 1995-05-24 1996-05-23 2-Aminobenzoxazinoner til behandling af virale infektioner

Country Status (15)

Country Link
US (3) US5985872A (da)
EP (1) EP0828721B1 (da)
JP (1) JPH11505849A (da)
CN (1) CN1070480C (da)
AT (2) ATE270667T1 (da)
AU (1) AU711174B2 (da)
BR (1) BR9608506A (da)
CA (1) CA2222034A1 (da)
DE (2) DE69617005T2 (da)
DK (1) DK0828721T3 (da)
ES (2) ES2169242T3 (da)
NZ (1) NZ308398A (da)
PT (2) PT1122245E (da)
TW (1) TW455583B (da)
WO (1) WO1996037485A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1122245B1 (en) * 1995-05-24 2004-07-07 G.D. Searle & Co. 2-Amino-benzoxazinones for the treatment of viral infections
US5985872A (en) * 1995-05-24 1999-11-16 G.D. Searle & Co. 2-amino-benzoxazinones for the treatment of viral infections
WO1997048707A1 (en) * 1996-06-20 1997-12-24 Smithkline Beecham Plc 4h-3,1-benzoxazin-4-one derivatives and analogs as antiviral agents
GB9710928D0 (en) * 1997-05-29 1997-07-23 Smithkline Beecham Plc Pharmaceuticals
GB9900416D0 (en) * 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
AR022204A1 (es) * 1999-01-08 2002-09-04 Norgine Bv Compuesto, proceso para su preparacion, composicion farmaceutica y producto comestible que lo comprende.
US6806269B1 (en) * 1999-07-12 2004-10-19 G. D. Searle & Cop 2-Amino-benzoxazinones for the treatment of herpes simplex virus
HK1046862A1 (zh) * 1999-07-12 2003-01-30 G.D. Searle & Co. 用於治疗单纯疱疹病毒的2-氨基-苯并恶嗪酮
DE10036184A1 (de) * 2000-07-24 2002-02-14 Aventis Cropscience Gmbh Substituierte Sulfonylaminomethylbenzoesäure(derivate) und Verfahren zu ihrer Herstellung
WO2003002558A1 (en) * 2001-06-13 2003-01-09 Asahi Kasei Pharma Corporation Remedial agent for viral infectious disease
WO2004046090A2 (en) * 2002-11-21 2004-06-03 Neurosearch A/S Aryl ureido derivatives and their medical use
US7192471B2 (en) * 2004-09-24 2007-03-20 Honeywell International Inc. Aryl-ureido benzoxazinone compounds
ATE549321T1 (de) 2006-11-22 2012-03-15 Ajinomoto Kk Verfahren zur herstellung von phenylalaninderivaten mit chinazolindiongerüsten, und zwischenprodukte für die herstellung
EP2213655A1 (en) * 2007-04-27 2010-08-04 Paratek Pharmaceuticals, Inc. Methods For Purifying Aminoalkyl Tetracycline Compounds
US8356971B2 (en) * 2009-12-17 2013-01-22 Detch John W Disc turbine with streamlined hub vanes and co-axial exhaust tube
CN115109006B (zh) * 2022-05-20 2025-03-14 上海大学 一种3-取代-1,2-苯并噁嗪-4-酮类化合物的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297755A (en) * 1960-12-02 1967-01-10 Hoffmann La Roche 2-chloro-5-trifluoromethylbenzo-phenone compounds
US3450700A (en) * 1966-12-20 1969-06-17 Upjohn Co 2-tertiary amino-4h-3,1-benzoxazin-4-ones
DE2218302A1 (de) * 1972-04-15 1973-10-25 Bayer Ag Verfahren zur herstellung von trifluormethylimino-derivaten von benzoxazinonen
DE2315303A1 (de) * 1973-03-27 1974-10-17 Bayer Ag Verfahren zur herstellung von n-substituierten 2-amino-3,1-benzoxazin-4-onen
NZ210669A (en) * 1983-12-27 1988-05-30 Syntex Inc Benzoxazin-4-one derivatives and pharmaceutical compositions
US4657893A (en) * 1984-05-09 1987-04-14 Syntex (U.S.A.) Inc. 4H-3,1-benzoxazin-4-ones and related compounds and use as enzyme inhibitors
US4745116A (en) * 1985-06-25 1988-05-17 Syntex (U.S.A.) Inc. 2-oxy-4H-3,1-benzoxazin-4-ones and related compounds and pharmaceutical use
US4665070A (en) * 1985-06-25 1987-05-12 Syntex (U.S.A.) Inc. 2-oxy-4H-3,1-benzoxazin-4-ones and pharmaceutical use
CA1309556C (en) * 1987-06-09 1992-10-27 Masayuki Kokubo 4h-3,1-benzoxazin-4-one compounds and pharmaceutical composition thereoffor the inhibition of serine proteases
JP2685648B2 (ja) * 1990-02-15 1997-12-03 帝人株式会社 4h−3.1−ベンズオキサジン−4−オン化合物
WO1992018488A1 (en) * 1991-04-10 1992-10-29 Japan Tobacco Inc. Novel oxazinone derivative
NZ242739A (en) * 1991-05-24 1994-12-22 Arch Dev Corp Identification and purification of herpes protease nucleic acid segments and their use in the production of this protease
US5434074A (en) * 1991-07-05 1995-07-18 Gibson; D. Wade Cytomegalovirus proteinase
US5428021A (en) * 1994-01-27 1995-06-27 Sri International Human leukocyte elastase (HLE) inhibitors, and related pharmaceutical compositions and methods of use
US5652237A (en) * 1994-09-09 1997-07-29 Warner-Lambert Company 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes
EP1122245B1 (en) * 1995-05-24 2004-07-07 G.D. Searle & Co. 2-Amino-benzoxazinones for the treatment of viral infections
US5985872A (en) 1995-05-24 1999-11-16 G.D. Searle & Co. 2-amino-benzoxazinones for the treatment of viral infections

Also Published As

Publication number Publication date
JPH11505849A (ja) 1999-05-25
CN1190963A (zh) 1998-08-19
PT1122245E (pt) 2004-11-30
PT828721E (pt) 2002-04-29
DE69617005D1 (de) 2001-12-20
AU711174B2 (en) 1999-10-07
DE69632876T2 (de) 2005-03-03
CA2222034A1 (en) 1996-11-28
ATE208765T1 (de) 2001-11-15
AU5803096A (en) 1996-12-11
DE69617005T2 (de) 2002-07-04
ES2169242T3 (es) 2002-07-01
BR9608506A (pt) 1999-06-15
DE69632876D1 (de) 2004-08-12
US6683077B2 (en) 2004-01-27
ES2225339T3 (es) 2005-03-16
EP0828721A1 (en) 1998-03-18
US5985872A (en) 1999-11-16
ATE270667T1 (de) 2004-07-15
CN1070480C (zh) 2001-09-05
EP0828721B1 (en) 2001-11-14
WO1996037485A1 (en) 1996-11-28
US20050032793A1 (en) 2005-02-10
NZ308398A (en) 1999-06-29
US20030022895A1 (en) 2003-01-30
TW455583B (en) 2001-09-21

Similar Documents

Publication Publication Date Title
DE69803907D1 (de) Fungizide 2-Methoxybenzophenone
DK0828721T3 (da) 2-Aminobenzoxazinoner til behandling af virale infektioner
PT931788E (pt) Inibidores de metaloprotease
NO920767L (no) Pyranylcyanoguanidin-derivater
ES2163638T3 (es) Nuevas n-(1-alquil-5-fenil-2,3,4,5-tetrahidro-1h-benzo(b)(1,5)diacepin-3-il)acetamidas.
EA200201083A1 (ru) Противоопухолевые производные эктейнасцидина
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
DK0903347T3 (da) Hidtil ukendte cyclodepsipeptid PF1022-derivater
TR200002932T2 (tr) Azabisayklik 5HT1 Alıcı liganolları
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
ATE250021T1 (de) Hydroxycyclopentanone
ES2181790T3 (es) Compuestos azaciclohexapeptidicos.
DK0779895T3 (da) Forbedret fremgangsmåde til fremstilling af sidekædederivater af cyclohexapeptidyl-lipopeptider
DK1178985T3 (da) Substituerede thienocycloalk(en)ylamino-1,3,5-triaziner
DK0915858T3 (da) Mellemprodukter til fremstilling af 2-imidazolin-5-oner
MX9709016A (es) 2-amino-benzoxazinonas, composiciones que las contienen y uso de las mismas.
DK1140932T3 (da) Derivater af benzo-1,8-naphtyridin
ES2195309T3 (es) Derivados de tetrahidrofurano.
DE60108242D1 (de) Herstellung von hydroxyverbindungen